| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |